about
The dendritic hypothesis for Alzheimer's disease pathophysiology.Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET.Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.Advances in understanding the mechanisms and management of persistent pain in older adults.Advances in the pharmacotherapy of Alzheimer's disease.Biochemistry of DementiasClinically tested drugs for Alzheimer's disease.Therapeutic approaches to age-associated neurocognitive disordersNeocortical morphometry and cholinergic neurochemistry in Pick's disease.Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia.A meta-analysis of the effects of aging on motor cortex neurophysiology assessed by transcranial magnetic stimulationAcetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: do we need new inhibitors?Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity.Effects of Ncl. Basalis Meynert volume on the Trail-Making-Test are restricted to the left hemisphere.Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease.Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease.Functional activation of Gαq coupled to 5-HT2A receptor and M1 muscarinic acetylcholine receptor in postmortem human cortical membranes.Critical review of clinical trials in senile dementia--II.Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells.A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?The nucleus basalis of Meynert in neurological dementing disease: a review.The cortical dementias.Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression.Neurotransmitter deficits in Alzheimer's disease: criteria for significance.Biochemistry of Alzheimer's dementia.Drug therapy in the elderly: the clinical pharmacology of aging.Central anticholinergic hypersensitivity in aging.Peripheral catecholamine enzyme function and cognitive impairment of elderly schizophrenics and controls.Dexamethasone suppression test and response to antidepressant therapy in psychogeriatric patients.Scopolamine reduces frontal cortex perfusion.Omental transposition to the brain for Alzheimer's disease.[14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortexReduction in muscarinic receptor binding in limbic areas of Alzheimer brain.A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain.Metabolic alterations in the hypothalamus and basal forebrain in vascular dementia.Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
P2860
Q27687404-7492574A-A848-46CE-B9C3-2AFC61196D49Q31911220-745E4454-34A8-4E60-BDBF-00EE499CC676Q33618671-566A5265-5E3E-4FB7-AFEF-AE8078FCF493Q33621285-DE70D075-10EB-4B38-A753-31D528DACD99Q33739635-73B619D6-6074-49D4-AB19-E6483473B9C5Q34011160-D200609E-0F19-4A95-AEC1-9D222776FCA0Q34982070-2CDA89F4-F4A5-440E-97E7-216317607A80Q35164747-27642A50-ECA2-4736-B85E-961053B6651EQ35236387-35116A77-0E16-4E23-B7BD-3E4CCECD51DEQ35818792-9938BEEE-5EAC-46EC-AE5B-CBD4FF50FDE0Q35838504-12253FCC-280B-46CD-9252-DD4920E5CE8DQ35844609-D09CAA7C-2701-41C7-BA5A-D0FB5DF47FC3Q36078030-5459C761-67B1-4959-85FA-01AC0485C353Q36302845-A2B806C9-2F2B-4A5A-86E0-E1687FA6F6EEQ36713096-57434FDB-E3D3-4C1F-B572-4732DEDF6906Q36807678-F0112641-21FF-4240-9CBF-AC8459BD2F5FQ37672243-24457662-D5DE-4988-91CD-A056514F8DC2Q38069821-64D2E4EA-84B6-4CBF-B5FE-EB78E653B33AQ38596419-9AC84040-8D81-4BD7-9CB0-5C7BB5105CB7Q38661128-B765D2C8-0268-4CA8-BE7B-9D6C50EA640BQ39173624-E390A946-9724-4AAC-BE31-C027DE2FB8D5Q39275304-C952CDFC-BC68-4F2C-8DA3-07C7C8698BAFQ39451637-ACC53461-0FD9-499E-A0FB-456A5AC94FE0Q39483754-99B44217-6608-4388-AC6F-5BD9E6E175F3Q39554675-50DBFE5D-BE3B-4728-9044-DF2BEB20B82DQ39775828-06092519-BD19-4136-A763-9C9D8E026380Q40089993-5A186E2E-ECDD-474F-A1EA-D40B3889E971Q40264745-A58DE15D-DE0B-40DF-B92E-BC468F0C300FQ40875061-788923F3-F0F7-4626-A528-FECBA2DC5906Q41084079-FE09E886-EB1F-4B81-A2EE-9C8437B9C41CQ41431180-8645D51D-F74A-4A94-B32E-6862A4E0182FQ41440662-267A78F6-054C-4F90-A031-7B448A40956BQ41441626-A69D6401-ABF7-4CD5-9EFE-F9E31CCC3A9FQ41611122-1CFCAD96-DB0B-4EBA-87C7-11012DC8E855Q41847403-A6A8074A-D8D2-4FA0-ACA4-70CE0F7B85A9Q41962167-A0A1A43D-39F2-4714-86B2-CD18EB3E5B5FQ42150542-E504B34E-5F09-4F0F-8316-B8D7DBAF7CC5Q42446821-2F181321-3D69-493A-A0F4-D1042FD73338Q42472368-8D00AA5A-4BE6-4187-A02B-85C84C9CF4E2Q42473091-5178F52B-4D68-43BD-9F95-CDC22D060F81
P2860
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Neocortical cholinergic neurons in elderly people.
@en
Neocortical cholinergic neurons in elderly people.
@nl
type
label
Neocortical cholinergic neurons in elderly people.
@en
Neocortical cholinergic neurons in elderly people.
@nl
prefLabel
Neocortical cholinergic neurons in elderly people.
@en
Neocortical cholinergic neurons in elderly people.
@nl
P2093
P1433
P1476
Neocortical cholinergic neurons in elderly people.
@en
P2093
I E Williams
L H Carrasco
M J Goodhardt
P304
P356
10.1016/S0140-6736(77)92114-6
P407
P577
1977-03-01T00:00:00Z